Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8690-8696

  Shen, Y ^a   Shen, L ^a   Sehgal, P ^a   Zhou, D ^a   Simon, M ^a   Miller, M ^a   Enimi, E A ^a   Henckler, B ^a   Chalifoux, L ^a   Sehgal, N ^a   Gastron, M ^a   Letvin, N L ^a   Chen, Z W ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; TENOFOVIR; TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; MACACA; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; T LYMPHOCYTE; TUBERCULOSIS; VIRUS INHIBITION; VIRUS REPLICATION;

ADENINE; ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; HIV PROTEASE INHIBITORS; INDINAVIR; MACACA MULATTA; MACACA NEMESTRINA; MYCOBACTERIUM BOVIS; NELFINAVIR; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0034881383     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8690-8696.2001     Document Type: Article

References (25)

1. Tuberculosis in patients with human immunodeficiency virus infection
2. + T lymphocyte subpopulation in tuberculous pleuritis
3. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus
4. Disseminated granulomatous disease in a simian immunodeficiency virus-and bacille Calmette-Guerin-infected rhesus monkey
5. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms
6. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92
7. Correlates of protective immunity to Mycobacterium tuberculosis in humans
8. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection
9. Tuberculosis in patients with human immunodeficiency virus infection
10. Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects
11. The global problem of multidrug-resistant tuberculosis: The genie is out of the bottle
12. Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy
13. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy
14. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
15. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
16. + T cells
17. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis
18. Virulence of recent notorious Mycobacterium tuberculosis isolates
19. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2
20. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
21. CD1-restricted T cell recognition of microbial lipoglycan antigens
22. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: Requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects
23. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
24. Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: A role of persistent T cell activation in AIDS pathogenesis